US 7867977
Immunogenic peptides and methods of use for treating and preventing cancer
granted A61KA61K39/0011A61K40/11
Quick answer
US patent 7867977 (Immunogenic peptides and methods of use for treating and preventing cancer) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K39/0011, A61K40/11, A61K40/42, A61P